Spruce Biosciences, Inc. (SPRB) Free cash flow 2019–2024
Spruce Biosciences, Inc. (SPRB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$56.0MFY2024 · since FY2019: -$12.6M → -$56.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$56.0M | -68.2% |
| FY2023 | -$33.3M | +20.2% |
| FY2022 | -$41.7M | -15.9% |
| FY2021 | -$36.0M | -30.4% |
| FY2020 | -$27.6M | -118.6% |
| FY2019 | -$12.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More SPRB financial trends
SPRB RevenueSPRB Net incomeSPRB Net marginSPRB Gross profitSPRB Gross marginSPRB Operating incomeSPRB Operating marginSPRB Operating cash flowSPRB Capital expendituresSPRB Return on equitySPRB Stock buybacksSPRB Dividends paidSPRB Total assetsSPRB Total liabilitiesSPRB Shareholders’ equitySPRB overview →